Technology

Ampio Pharmaceuticals

$1.54
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.14 (+10.29%) Today
+$0.04 (+2.67%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell AMPE and other stocks, options, and ETFs commission-free!

About AMPE

Ampio Pharmaceuticals, Inc, also called Ampio Pharmaceuticals, is a biopharmaceutical company that engages in the development of therapies to treat prevalent inflammatory conditions. Its product pipeline includes new uses for approved drugs and new molecular entities for important therapeutic areas, including metabolic disease, eye disease, kidney disease, inflammation, and sexual dysfunction and CNS disease. The company was founded by David Bar-Or in April 2010 and is headquartered in Englewood, CO. The listed name for AMPE is Ampio Pharmaceuticals, Inc.

CEO
Michael E. Macaluso
Employees
23
Headquarters
Englewood, Colorado
Founded
2010
Market Cap
291.87M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.70M
High Today
$1.60
Low Today
$1.35
Open Price
$1.40
Volume
7.02M
52 Week High
$2.98
52 Week Low
$0.31

Collections

AMPE Earnings

-$0.02
-$0.01
-$0.01
$0.00
Q2 FY19
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Estimated
— per share
Actual
Expected Feb 28, Pre-Market

You May Also Like

EVFM
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure